These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 12684361

  • 1. Zonisamide for weight loss in obese adults: a randomized controlled trial.
    Gadde KM, Franciscy DM, Wagner HR, Krishnan KR.
    JAMA; 2003 Apr 09; 289(14):1820-5. PubMed ID: 12684361
    [Abstract] [Full Text] [Related]

  • 2. Combination therapy of zonisamide and bupropion for weight reduction in obese women: a preliminary, randomized, open-label study.
    Gadde KM, Yonish GM, Foust MS, Wagner HR.
    J Clin Psychiatry; 2007 Aug 09; 68(8):1226-9. PubMed ID: 17854247
    [Abstract] [Full Text] [Related]

  • 3. Atomoxetine for weight reduction in obese women: a preliminary randomised controlled trial.
    Gadde KM, Yonish GM, Wagner HR, Foust MS, Allison DB.
    Int J Obes (Lond); 2006 Jul 09; 30(7):1138-42. PubMed ID: 16418753
    [Abstract] [Full Text] [Related]

  • 4. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
    Muls E, Kolanowski J, Scheen A, Van Gaal L, ObelHyx Study Group.
    Int J Obes Relat Metab Disord; 2001 Nov 09; 25(11):1713-21. PubMed ID: 11753595
    [Abstract] [Full Text] [Related]

  • 5. Weight changes in obese adults 6-months after discontinuation of double-blind zonisamide or placebo treatment.
    Shin JH, Gadde KM, Østbye T, Bray GA.
    Diabetes Obes Metab; 2014 Aug 09; 16(8):766-8. PubMed ID: 25123600
    [Abstract] [Full Text] [Related]

  • 6. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
    Greenway FL, Fujioka K, Plodkowski RA, Mudaliar S, Guttadauria M, Erickson J, Kim DD, Dunayevich E, COR-I Study Group.
    Lancet; 2010 Aug 21; 376(9741):595-605. PubMed ID: 20673995
    [Abstract] [Full Text] [Related]

  • 7. Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women.
    Gadde KM, Parker CB, Maner LG, Wagner HR, Logue EJ, Drezner MK, Krishnan KR.
    Obes Res; 2001 Sep 21; 9(9):544-51. PubMed ID: 11557835
    [Abstract] [Full Text] [Related]

  • 8. Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study.
    Ettinger MP, Littlejohn TW, Schwartz SL, Weiss SR, McIlwain HH, Heymsfield SB, Bray GA, Roberts WG, Heyman ER, Stambler N, Heshka S, Vicary C, Guler HP.
    JAMA; 2003 Apr 09; 289(14):1826-32. PubMed ID: 12684362
    [Abstract] [Full Text] [Related]

  • 9. The effect of the dietary supplement, Chitosan, on body weight: a randomised controlled trial in 250 overweight and obese adults.
    Mhurchu CN, Poppitt SD, McGill AT, Leahy FE, Bennett DA, Lin RB, Ormrod D, Ward L, Strik C, Rodgers A.
    Int J Obes Relat Metab Disord; 2004 Sep 09; 28(9):1149-56. PubMed ID: 15311218
    [Abstract] [Full Text] [Related]

  • 10. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.
    Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J, RIO-North America Study Group.
    JAMA; 2006 Feb 15; 295(7):761-75. PubMed ID: 16478899
    [Abstract] [Full Text] [Related]

  • 11. Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial.
    McElroy SL, Kotwal R, Guerdjikova AI, Welge JA, Nelson EB, Lake KA, D'Alessio DA, Keck PE, Hudson JI.
    J Clin Psychiatry; 2006 Dec 15; 67(12):1897-906. PubMed ID: 17194267
    [Abstract] [Full Text] [Related]

  • 12. Zonisamide for weight reduction in obese adults: a 1-year randomized controlled trial.
    Gadde KM, Kopping MF, Wagner HR, Yonish GM, Allison DB, Bray GA.
    Arch Intern Med; 2012 Nov 12; 172(20):1557-64. PubMed ID: 23147455
    [Abstract] [Full Text] [Related]

  • 13. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial.
    Chanoine JP, Hampl S, Jensen C, Boldrin M, Hauptman J.
    JAMA; 2005 Jun 15; 293(23):2873-83. PubMed ID: 15956632
    [Abstract] [Full Text] [Related]

  • 14. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects.
    Wilding J, Van Gaal L, Rissanen A, Vercruysse F, Fitchet M, OBES-002 Study Group.
    Int J Obes Relat Metab Disord; 2004 Nov 15; 28(11):1399-410. PubMed ID: 15486569
    [Abstract] [Full Text] [Related]

  • 15. A randomized phase III trial of adjunctive zonisamide in pediatric patients with partial epilepsy.
    Guerrini R, Rosati A, Segieth J, Pellacani S, Bradshaw K, Giorgi L.
    Epilepsia; 2013 Aug 15; 54(8):1473-80. PubMed ID: 23837461
    [Abstract] [Full Text] [Related]

  • 16. Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial.
    Astrup A, Madsbad S, Breum L, Jensen TJ, Kroustrup JP, Larsen TM.
    Lancet; 2008 Nov 29; 372(9653):1906-1913. PubMed ID: 18950853
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.
    Davies MJ, Bergenstal R, Bode B, Kushner RF, Lewin A, Skjøth TV, Andreasen AH, Jensen CB, DeFronzo RA, NN8022-1922 Study Group.
    JAMA; 2015 Aug 18; 314(7):687-99. PubMed ID: 26284720
    [Abstract] [Full Text] [Related]

  • 18. The effect of zonisamide on antipsychotic-associated weight gain in patients with schizophrenia: a randomized, double-blind, placebo-controlled clinical trial.
    Ghanizadeh A, Nikseresht MS, Sahraian A.
    Schizophr Res; 2013 Jun 18; 147(1):110-115. PubMed ID: 23583010
    [Abstract] [Full Text] [Related]

  • 19. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial.
    Fidler MC, Sanchez M, Raether B, Weissman NJ, Smith SR, Shanahan WR, Anderson CM, BLOSSOM Clinical Trial Group.
    J Clin Endocrinol Metab; 2011 Oct 18; 96(10):3067-77. PubMed ID: 21795446
    [Abstract] [Full Text] [Related]

  • 20. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study.
    Astrup A, Rössner S, Van Gaal L, Rissanen A, Niskanen L, Al Hakim M, Madsen J, Rasmussen MF, Lean ME, NN8022-1807 Study Group.
    Lancet; 2009 Nov 07; 374(9701):1606-16. PubMed ID: 19853906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.